Zarzoso-Foj, J.; Cuquerella-Gilabert, M.; Merino-Sanjuan, M.; Reig-Lopez, J.; Mangas-Sanjuán, V.; Garcia-Arieta, A.
Physiologically-Based Biopharmaceutics Modeling for Ibuprofen: Identifying Key Formulation Parameter and Virtual Bioequivalence Assessment. Pharmaceutics 2025, 17, 408.
https://doi.org/10.3390/pharmaceutics17040408
AMA Style
Zarzoso-Foj J, Cuquerella-Gilabert M, Merino-Sanjuan M, Reig-Lopez J, Mangas-Sanjuán V, Garcia-Arieta A.
Physiologically-Based Biopharmaceutics Modeling for Ibuprofen: Identifying Key Formulation Parameter and Virtual Bioequivalence Assessment. Pharmaceutics. 2025; 17(4):408.
https://doi.org/10.3390/pharmaceutics17040408
Chicago/Turabian Style
Zarzoso-Foj, Javier, Marina Cuquerella-Gilabert, Matilde Merino-Sanjuan, Javier Reig-Lopez, VÃctor Mangas-Sanjuán, and Alfredo Garcia-Arieta.
2025. "Physiologically-Based Biopharmaceutics Modeling for Ibuprofen: Identifying Key Formulation Parameter and Virtual Bioequivalence Assessment" Pharmaceutics 17, no. 4: 408.
https://doi.org/10.3390/pharmaceutics17040408
APA Style
Zarzoso-Foj, J., Cuquerella-Gilabert, M., Merino-Sanjuan, M., Reig-Lopez, J., Mangas-Sanjuán, V., & Garcia-Arieta, A.
(2025). Physiologically-Based Biopharmaceutics Modeling for Ibuprofen: Identifying Key Formulation Parameter and Virtual Bioequivalence Assessment. Pharmaceutics, 17(4), 408.
https://doi.org/10.3390/pharmaceutics17040408